Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013

Antimicrobial Resistance and Infection Control

Volumn 4, Issue 1, 2015, Pages

  Agodi, Antonella ^a,d   Barchitta, Martina ^a   Quattrocchi, Annalisa ^a   Maugeri, Andrea ^a   Aldisio, Eugenia ^b   Marchese, Anna Elisa ^b   Mattaliano, Anna Rita ^b   Tsakris, Athanassios ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antimicrobial resistance; Antimicrobial usage density; Resistance rates

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; ITALY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREND STUDY;

EID: 85006225979     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-015-0087-y     Document Type: Article

References (30)

1. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013.
2. World Health Organization. Antimicrobial resistance global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. 2014. Accessed 10 May 2015.
3. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1-55.
4. Agodi A, Auxilia F, Barchitta M, Brusaferro S, D'Alessandro D, Montagna MT, et al. Building a benchmark through active surveillance of ICU-acquired infections: the Italian network SPIN-UTI. J Hosp Infect. 2010;74:258-65.
5. Masia MD, Barchitta M, Liperi G, Cantù AP, Alliata E, Auxilia F, et al. Validation of intensive care unit-acquired infection surveillance in the Italian SPIN-UTI network. J Hosp Infect. 2010;76:139-42.
6. Agodi A, Auxilia F, Barchitta M, Brusaferro S, D'Alessandro D, Grillo OC, et al. Trends, risk factors and outcomes of healthcare-associated infections within the Italian network SPIN-UTI. J Hosp Infect. 2013;84:52-8.
7. European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe 2012. Stockholm: ECDC; 2014.
8. Goel N, Wattal C, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India. J Antimicrob Chemother. 2011;66:1625-30.
9. Agodi A, Barchitta M, Valenti G, Romeo MA, Giaquinta L, Santangelo C, et al. Cross-transmission of Klebsiella pneumoniae in two intensive care units: intra- and inter-hospital spread. J Hosp Infect. 2011;77:279-80.
10. Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, et al. Containment of an Outbreak of KPC-3 Carbapenemase-Producing Klebsiella pneumoniae in Italy. J Clin Microbiol. 2011;49:3986-9.
11. Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86:260-6.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement update. CLSI document. M100-MS20. Wayne, PA: CLSI; 2010.
13. European Committee on Antimicrobial Susceptibility Testing guidelines (EUCAST). http://www.eucast.org/clinical_breakpoints/. Accessed 15 May 2015.
14. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010;14:R113.
15. WHO collaborating centre for drug statistics methodology ATC/DDD index. http://www.whocc.no/atc_ddd_index/. Accessed 26 May 2015.
16. Ministero della Salute. Piano Nazionale della Prevenzione 2014-2018. http://www.quotidianosanita.it/allegati/create_pdf.php?all=9561948.pdf. Accessed 16 April 2015.
17. Ricchizzi E, Morsillo F, Buttazzi R, Pan A, Gagliotti C, Morandi M, et al. Studio di prevalenza europeo su infezioni correlate all'assistenza e uso di antibiotici negli ospedali per acuti. Rapporto nazionale. http://assr.regione.emilia-romagna.it/it/servizi/pubblicazioni/rapporti-documenti/studio-prevalenza-europeo-ICA-ospedali-acuti. 2013. Accessed 18 April 2015.
18. Agodi A, Zarrilli R, Barchitta M, Anzaldi A, Di Popolo A, Mattaliano A, et al. Alert-surveillance of ICU-acquired Acinetobacter infections in a Sicilian hospital. Clin Microbiol Infect. 2006;12:241-7.
19. Tan CK, Tang HJ, Lai CC, Chen YY, Chang PC, Liu WL. Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010. J Microbiol Immunol Infect. 2014;pii:S1684-1182(14)00033-4.
20. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003;31:208-15.
21. Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med. 2007;33:1155-61.
22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pan drug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81.
23. Magiorakos AP, Suetens C, Monnet DL, Gagliotti C, Heuer OE, EARS-Net Coordination Group and EARS-Net participants. The rise of carbapenem resistance in Europe: just the tip of the iceberg? Ant Res Infect Control. 2013;2:6.
24. Ministero della Salute. Circolare Sorveglianza, e controllo delle infezioni da batteri produttori di carbapenemasi (CPE) del 26.02.2013. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf;jsessionid=GPGfYQ2qMHE8BmEDb7tO5g__.sgc4-prd-sal?anno=0&codLeg=45499&parte=1%20&serie=. 2013. Accessed 26 April 2015.
25. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54:969-76.
26. European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm: ECDC; 2011.
27. Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Blázquez J. Antibiotics and antibiotic resistance: A bitter fight against evolution. Int J Med Microbiol. 2013;303:293-7.
28. World Health Organization. The evolving threat of antimicrobial resistance Options for action. WHO Press, World Health Organization, Geneva, Switzerland, 2012
29. Zou YM, Ma Y, Liu JH, Shi J, Fan T, Shan YY, et al. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis. 2014. doi: 10.1007/s10096-014-2293-6.
30. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568-85.